Literature DB >> 34606886

Autoantibodies Present in Hidradenitis Suppurativa Correlate with Disease Severity and Promote the Release of Proinflammatory Cytokines in Macrophages.

Carmelo Carmona-Rivera1, Liam J O'Neil2, Eduardo Patino-Martinez1, William D Shipman3, Chengsong Zhu4, Quan-Zhen Li4, Michelle L Kerns5, Leandra A Barnes6, Julie A Caffrey7, Sewon Kang5, Mariana J Kaplan1, Ginette A Okoye8, Angel S Byrd9.   

Abstract

Hidradenitis suppurativa (HS), also known as acne inversa, is a debilitating inflammatory skin disorder that is characterized by nodules that lead to the development of connected tunnels and scars as it progresses from Hurley stages I to III. HS has been associated with several autoimmune diseases, including inflammatory bowel disease and spondyloarthritis. We previously reported dysregulation of humoral immune responses in HS, characterized by elevated serum total IgG, B-cell activation, and antibodies recognizing citrullinated proteins. In this study, we characterized IgG autoreactivity in HS sera and lesional skin compared with those in normal healthy controls using an array-based high-throughput autoantibody screening. The Cy3-labeled anti-human assay showed the presence of autoantibodies against nuclear antigens, cytokines, cytoplasmic proteins, extracellular matrix proteins, neutrophil proteins, and citrullinated antigens. Most of these autoantibodies were significantly elevated in stages II‒III in HS sera and stage III in HS skin lesions compared with those of healthy controls. Furthermore, immune complexes containing both native and citrullinated versions of antigens can activate M1 and M2 macrophages to release proinflammatory cytokines such as TNF-α, IL-8, IL-6, and IL-12. Taken together, the identification of specific IgG autoantibodies that recognize circulating and tissue antigens in HS suggests an autoimmune mechanism and uncovers putative therapeutic targets.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34606886      PMCID: PMC8860851          DOI: 10.1016/j.jid.2021.07.187

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  76 in total

1.  Gamma-secretase gene mutations in familial acne inversa.

Authors:  Baoxi Wang; Wei Yang; Wen Wen; Jing Sun; Bin Su; Bo Liu; Donglai Ma; Dan Lv; Yaran Wen; Tao Qu; Min Chen; Miao Sun; Yan Shen; Xue Zhang
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

2.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

3.  Hidradenitis suppurativa disproportionately affects African Americans: a single-center retrospective analysis.

Authors:  Natalia Vlassova; Diane Kuhn; Ginette A Okoye
Journal:  Acta Derm Venereol       Date:  2015-11       Impact factor: 4.437

Review 4.  Innate immunity as a target for acute cardioprotection.

Authors:  Coert J Zuurbier; Antonio Abbate; Hector A Cabrera-Fuentes; Michael V Cohen; Massimo Collino; Dominique P V De Kleijn; James M Downey; Pasquale Pagliaro; Klaus T Preissner; Masafumi Takahashi; Sean M Davidson
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

Review 5.  Hidradenitis Suppurativa: Disease Burden and Etiology in Skin of Color.

Authors:  Dylan E Lee; Ashley K Clark; Vivian Y Shi
Journal:  Dermatology       Date:  2018-03-01       Impact factor: 5.366

6.  Transcriptome patterns in hidradenitis suppurativa: support for the role of antimicrobial peptides and interferon pathways in disease pathogenesis.

Authors:  V K Shanmugam; D Jones; S McNish; M L Bendall; K A Crandall
Journal:  Clin Exp Dermatol       Date:  2019-04-24       Impact factor: 3.470

7.  Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.

Authors:  G Kelly; R Hughes; T McGarry; M van den Born; K Adamzik; R Fitzgerald; C Lawlor; A M Tobin; C M Sweeney; B Kirby
Journal:  Br J Dermatol       Date:  2015-11-17       Impact factor: 9.302

8.  Detection of SLE antigens in neutrophil extracellular traps (NETs).

Authors:  Carmelo Carmona-Rivera; Mariana J Kaplan
Journal:  Methods Mol Biol       Date:  2014

Review 9.  Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events.

Authors:  Antonio Abbate; Benjamin W Van Tassell; Giuseppe G L Biondi-Zoccai
Journal:  BioDrugs       Date:  2012-08-01       Impact factor: 5.807

Review 10.  Hidradenitis suppurativa: infection, autoimmunity, or both?

Authors:  Costas A Constantinou; George E Fragoulis; Elena Nikiphorou
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-12-30       Impact factor: 5.346

View more
  2 in total

Review 1.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233

2.  Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander?

Authors:  K R van Straalen; K Dudink; P Aarts; H H van der Zee; T P P van den Bosch; J Giang; E P Prens; J Damman
Journal:  Front Immunol       Date:  2022-09-21       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.